P3 Health Partners Inc Warrant
PIIIW
18 hedge funds and large institutions have $636K invested in P3 Health Partners Inc Warrant in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
6% more funds holding
Funds holding: 17 → 18 (+1)
1% more capital invested
Capital invested by funds: $630K → $636K (+$6.44K)
0.28% less ownership
Funds ownership: 6.53% → 6.25% (-0.28%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$384 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$417 |
PIIIW Hedge Fund Activity: Q2 2024 in Review
18 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners Inc Warrant (PIIIW) for Q2 2024, worth a combined $636K — up 1% from $630K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PIIIW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $384. The largest seller was Walleye Capital, cutting an estimated $417.
- 18 institutional investors held P3 Health Partners Inc Warrant (PIIIW) as of Q2 2024, up from 17 in Q1 2024.
- Funds reported $636K of P3 Health Partners Inc Warrant stock for Q2 2024, up 1% quarter-over-quarter.
- 1 fund opened new P3 Health Partners Inc Warrant positions in Q2 2024 and 0 closed out, a net change of +1 holder.
- The largest P3 Health Partners Inc Warrant buyer in Q2 2024 was UBS Group, an estimated $384 added.
- The largest P3 Health Partners Inc Warrant seller in Q2 2024 was Walleye Capital, an estimated $417 sold.
Based on aggregated 13F filings for Q2 2024.